Progesterone + Ethinylestradiol Injection
- Packing: 1 Ml Ampoule, 1 ml PFS.
- Available Strength : 12.5 + 0.02 Mg
Description
Product Description: Progesterone + Ethinylestradiol Injection is a combination medication containing progesterone and ethinylestradiol, two synthetic hormones. It is formulated for injection and is used as a contraceptive method.
Indications and Usage: Progesterone + Ethinylestradiol Injection is indicated for the prevention of pregnancy in women of reproductive age. It works by inhibiting ovulation, thickening cervical mucus to prevent sperm penetration, and altering the endometrium to prevent implantation.
Dosage and Administration: The dosage of Progesterone + Ethinylestradiol Injection typically involves a series of injections given at specific intervals, such as every 1 to 3 months. The exact dosing regimen may vary depending on the specific product formulation and the patient's individual needs.
Dosage Forms and Strengths: Progesterone + Ethinylestradiol Injection is available as a sterile solution in vials or ampules. Each milliliter of solution contains a specific amount of progesterone and ethinylestradiol, typically ranging from 50 mg to 150 mg of progesterone and 5 mcg to 30 mcg of ethinylestradiol per mL.
Contraindications: Progesterone + Ethinylestradiol Injection is contraindicated in pregnant women, women with a history of thromboembolic disorders, liver dysfunction, hormone-sensitive malignancies, and hypersensitivity to any of the components of the formulation.
Warnings and Precautions: Before initiating therapy with Progesterone + Ethinylestradiol Injection, healthcare providers should evaluate patients for cardiovascular risk factors, including hypertension, diabetes, and smoking. Patients should be counseled on the potential risks and benefits of hormonal contraception, including the increased risk of thromboembolic events and other adverse effects.
Adverse Reactions/Side Effects: Common adverse reactions associated with Progesterone + Ethinylestradiol Injection include nausea, headache, breast tenderness, breakthrough bleeding, and changes in menstrual flow. Other potential side effects may include weight gain, mood changes, and allergic reactions.
Drug Interactions: Progesterone + Ethinylestradiol Injection may interact with other medications, including anticoagulants, anticonvulsants, antimicrobial agents, and herbal supplements. Healthcare providers should carefully evaluate patients for potential drug interactions before initiating therapy.
Use In Specific Populations Description: Progesterone + Ethinylestradiol Injection is not recommended for use in pregnant women or women who are breastfeeding. It should be used with caution in women with a history of cardiovascular disease, liver dysfunction, or other medical conditions that may increase the risk of adverse effects.
How Supplied/Storage and Handling: Progesterone + Ethinylestradiol Injection is supplied as a sterile solution in vials or ampules. It should be stored at controlled room temperature, protected from light and moisture. Unused portions should be discarded according to local regulations for biohazardous waste disposal.